Envista Holdings Corp
NYSE:NVSTMedical - Equipment & Services
+$0.76 today
- Market cap
- $3.81B
- Beta
- 0.89
- P/E (TTM)
- 62.0
- EPS (TTM)
- $0.41
Volume 1.92M
Average 2.94M
NVST Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Envista Holdings CorpNYSE: NVST
Accounts Receivables · Q3 FY2026 · quarter ended Oct 2026
Accounts receivables turns negative
Q3 FY2026 accounts receivables was -$9.2M, compared with $13.6M a year earlier. Trailing-twelve-month accounts receivables was -$61.9M. Over 3 fiscal years it compounded at -11.9% a year.
Context
- Accounts receivables amounted to 1.8% of revenue in FY2025, up 1.4 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$9.2M or moves back toward the trailing-twelve-month quarterly average of -$15.48M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (48.5M) USD
- Year-over-year change
- -585.0%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (48.5M) | -585.0% |
| FY2024 | 2024-12-31 | 10M | +158.8% |
| FY2023 | 2023-12-31 | (17M) | +76.1% |
| FY2022 | 2022-12-31 | (71M) | -64.4% |
| FY2021 | 2021-12-31 | (43.2M) | — |
Accounts Receivables vs competitors
How NVST compares with its peers on the latest reported figures
- NVST's LTM Oct 2026 accounts receivables of $61.9M is the 2nd largest of the 11 companies compared; the peer median is $18.72M.
- Its year-over-year change of +387.4% is the highest of 9, against a peer median of -47.8%.
- Accounts receivables amounts to 2.2% of revenue for NVST, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $87.55M | +41.1% | -20.2% | 3.7% | |
| LTM Oct 2026 | $61.9M | +387.4% | -11.9% | 2.2% | |
| LTM Jun 2026 | $47.41M | -506.5% | +10.9% | 5.7% | |
| LTM Mar 2026 | $30.77M | -37.4% | +42.8% | 0.7% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $28.63M | +47.8% | +23.4% | 1.2% |
| LTM Mar 2026 | $22.06M | -1708.0% | +37.0% | 3.3% | |
| LTM Jun 2026 | $15.38M | -58.3% | — | 0.7% | |
| LTM Jun 2026 | $5.68M | +71.1% | — | 3.4% | |
| LTM Jun 2026 | $0 | — | — | — | |
| LTM Jun 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding NVST) | $18.72M | -47.8% | +23.4% | 2.3% | |
Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 340.5M | 243.1M | (100.2M) | (1.12B) | 47M |
| Depreciation & Amortization | 151.9M | 162.1M | 162.6M | 123.1M | 116M |
| Deferred Income Tax | 0 | 0 | (37M) | (29M) | 11.4M |
| Stock-Based Compensation | 28.2M | 30.5M | 30.7M | 35.3M | 37.6M |
| Change in Working Capital | (203.2M) | (271.7M) | (108.4M) | 97.4M | 8.9M |
| Accounts Receivables | (43.2M) | (71M) | (17M) | 10M | (48.5M) |
| Inventory | (66M) | (39.9M) | 35.1M | 3.6M | (29.1M) |
| Accounts Payables | (20.3M) | 44.5M | (46.3M) | (1.2M) | 7.5M |
| Other Working Capital | (73.7M) | (205.3M) | (80.2M) | 85M | 79M |
| Other Non-Cash Items | 44.2M | 18.7M | 328M | 1.23B | 54.8M |
| Operating Cash Flow | 361.6M | 182.7M | 275.7M | 336.5M | 275.7M |
| Capital Expenditures | (54.7M) | (75.7M) | (58.2M) | (33.8M) | (45.3M) |
| Acquisitions (Net) | 310.4M | (622.3M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (32.8M) | (9.9M) |
| Sales of Investments | 11.4M | 56M | 10.7M | 9.7M | 10.4M |
| Other Investing Activities | (4.4M) | (15.3M) | (14.9M) | 2.3M | (6.3M) |
| Investing Cash Flow | 262.7M | (657.3M) | (62.4M) | (54.6M) | (51.1M) |
| Debt Repayment | (475.7M) | (200K) | 115.4M | (100M) | (900K) |
| Common Stock Issued | 19.5M | 21.8M | 11.3M | 2.4M | 2.8M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (166.6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.4M) | (9.1M) | (7.8M) | (6.1M) | (6.2M) |
| Financing Cash Flow | (465.6M) | 12.5M | 118.9M | (103.7M) | (170.9M) |
| Effect of Forex Changes | 26M | (4.6M) | 900K | (49.1M) | 88.9M |
| Net Change in Cash | 184.7M | (466.7M) | 333.1M | 129.1M | 142.6M |
| Free Cash Flow | 306.9M | 107M | 217.5M | 302.7M | 230.4M |
Envista Holdings Corp
NYSE:NVST
Intrinsic Alpha fair value
Locked
Current Price
$23.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.